Bristol-Myers Squibb
BMY
BMY
1,532 hedge funds and large institutions have $88.6B invested in Bristol-Myers Squibb in 2015 Q4 according to their latest regulatory filings, with 169 funds opening new positions, 543 increasing their positions, 561 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.75% more ownership
Funds ownership: 73.29% → 74.03% (+0.75%)
3% less repeat investments, than reductions
Existing positions increased: 543 | Existing positions reduced: 561
31% less call options, than puts
Call options by funds: $554M | Put options by funds: $798M
Holders
1,532
Holding in Top 10
97
Calls
$554M
Puts
$798M
Top Buyers
| 1 | +$473M | |
| 2 | +$332M | |
| 3 | +$307M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$192M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$165M |
Top Sellers
| 1 | -$3.14B | |
| 2 | -$743M | |
| 3 | -$585M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$267M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$190M |